Lilly's psoriatic arthritis drug succeeds in late-stage study
April 20, 2015 at 08:13 AM EDT
April 20 (Reuters) - Eli Lilly and Co said its experimental drug, ixekizumab, was more effective than a placebo in patients with active psoriatic arthritis, in a late-stage trial.
